News | Artificial Intelligence | January 13, 2020

Artificial Intelligence Can Detect Low-glucose Levels via ECG Without Fingerpick

Fingerpicks deter patient compliance in tracking glucose levels but new technology might eliminate the need for blood sampling

A new technology for detecting low glucose levels via electrocardiogram (ECG) using a non-invasive wearable sensor, which with the latest artificial intelligence (AI) can detect hypoglycemic events from raw ECG signals has been made by researchers from the University of Warwick.

A new technology for detecting low glucose levels via electrocardiogram (ECG) using a non-invasive wearable sensor, which with the latest artificial intelligence (AI) can detect hypoglycemic events from raw ECG signals has been made by researchers from the University of Warwick.

 


January 13, 2020 — A new technology for detecting low glucose levels via electrocardiogram (ECG) using a non-invasive wearable sensor, which with the latest artificial intelligence (AI) can detect hypoglycemic events from raw ECG signals has been made by researchers from the University of Warwick.

Currently continuous glucose monitors (CGM) are available by the U.K. National Health Service (NHS) for hypoglycemia detection (sugar levels into blood or derma). They measure glucose in interstitial fluid using an invasive sensor with a little needle, which sends alarms and data to a display device. In many cases, they require calibration twice a day with invasive finger-prick blood glucose level tests.

However, the team of Leandro Pecchia, Ph.D., at the University of Warwick today published results in a paper titled "Precision Medicine and Artificial Intelligence: A Pilot Study on Deep Learning for Hypoglycemic Events Detection based on ECG," in the journal Nature Scientific Reports.[1] It shows that using the latest findings of deep learning they can detect hypoglycemic events from raw ECG signals acquired with off-the-shelf non-invasive wearable sensors.

Two pilot studies with healthy volunteers found the average sensitivity and specificity approximately 82 percent for hypoglycemia detection, which is comparable with the current CGM performance, although non-invasive.

“Fingerpicks are never pleasant and in some circumstances are particularly cumbersome," Pecchia said. "Taking fingerpick during the night certainly is unpleasant, especially for patients in pediatric age. Our innovation consisted in using artificial intelligence for automatic detecting hypoglycemia via few ECG beats. This is relevant because ECG can be detected in any circumstance, including sleeping.”

The figure shows the output of the algorithms over the time: the green line represents normal glucose levels, while the red line represents the low glucose levels. The horizontal line represents the 4 mmol/L glucose value, which is considered the significant threshold for hypoglycemic events. The grey area surrounding the continuous line reflects the measurement error bar.

The Warwick model highlights how the ECG changes in each subject during a hypoglycaemic event. Figure is an example. The solid lines represent the average heartbeats for two different subjects when the glucose level is normal (green line) or low (red line). The red and green shadows represent the standard deviation of the heartbeats around the mean. A comparison highlights that these two subjects have different ECG waveform changes during hypo events. In particular, Subject 1 presents a visibly longer QT interval during hypo, while the subject 2 does not.

Figure_1_ECG_AI_detects_Blood_Sugar_levelFigure 1 — The solid lines represent the average heartbeats for two different subjects when the glucose level is normal (green line) or low (red line). The red and green shadows represent the standard deviation of the heartbeats around the mean. A comparison highlights that these two subjects have different ECG waveform changes during hypo events. In particular, Subject 1 presents a visibly longer QT interval during hypo, while the subject 2 does not.

 

The vertical bars represent the relative importance of each ECG wave in determining if a heartbeat is classified as hypo or normal.

From these bars, a trained clinician sees that for Subject 1, the T-wave displacement influences classification, reflecting that when the subject is in hypo, the repolarization of the ventricles is slower.

In Subject 2, the most important components of the ECG are the P-wave and the rising of the T-wave, suggesting that when this subject is in hypo, the depolarization of the atria and the threshold for ventricular activation are particularly affected. This could influence subsequent clinical interventions.

This result is possible because the Warwick AI model is trained with each subject’s own data. Intersubjective differences are so significant, that training the system using cohort data would not give the same results. Likewise, personalized therapy based on our system could be more effective than current approaches.

“The differences highlighted above could explain why previous studies using ECG to detect hypoglycemic events failed. The performance of AI algorithms trained over cohort ECG-data would be hindered by these inter-subject differences," Pecchia explained. “Our approach enable personalized tuning of detection algorithms and emphasize how hypoglycemic events affect ECG in individuals. Basing on this information, clinicians can adapt the therapy to each individual. Clearly more clinical research is required to confirm these results in wider populations. This is why we are looking for partners.” 

Reference:

1. Mihaela Porumb, Saverio Stranges, Antonio Pescapè, et. al. Precision Medicine and Artificial Intelligence: A Pilot Study on Deep Learning for Hypoglycemic Events Detection based on ECG. Nature, Scientific Reports. Vol. 10, Article number: 170 (2020). Published: 13 January 2020. 
 


Related Content

News | Artificial Intelligence

July 18, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, introduced ...

Home July 18, 2024
Home
News | Artificial Intelligence

July 18, 2024 — AliveCor, a global leader in AI-powered cardiology, today announced that the American Medical ...

Home July 18, 2024
Home
News | Artificial Intelligence

July 17, 2024 — HeartFlow, a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced ...

Home July 17, 2024
Home
News | Artificial Intelligence

July 11, 2024 — Heart Test Laboratories, Inc. an artificial intelligence (AI)-powered medical technology company focused ...

Home July 11, 2024
Home
News | Artificial Intelligence

June 26, 2024 — Anumana, a leading AI-driven health technology company and portfolio company of nference, and InfoBionic ...

Home June 26, 2024
Home
News | Artificial Intelligence

June 25, 2024 — Nano-X Imaging (Nanox), an innovative medical imaging technology company, today announced that data from ...

Home June 25, 2024
Home
News | Artificial Intelligence

June 25, 2024 — AliveCor, the global leader in AI-powered cardiology, today announced the U.S. Food and Drug ...

Home June 25, 2024
Home
News | Artificial Intelligence

June 24, 2024 — HeartFocus, the revolutionary, AI-driven heart exam software by DESKi, a provider of automated, accurate ...

Home June 24, 2024
Home
News | Artificial Intelligence

June 21, 2024 — Cardiomatics, a pioneer in AI-powered ECG analysis solutions, and the Biotronik sales organization for ...

Home June 21, 2024
Home
Feature | Artificial Intelligence | By Gareth Jones

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the ...

Home June 19, 2024
Home
Subscribe Now